CrystecPharma will attend the 14th MIBio Conference, taking place on 14 October 2026 at the Howard Theatre, Downing College, Cambridge.
MIBio 2026 will bring together experts from across the biopharmaceutical industry and academia to explore how advances in molecular interactions can support the development of safer, more effective and patient-friendly therapeutic products.
This year’s conference will examine important developments in biopharmaceutical formulation and drug delivery, including concentrated dosage forms, prefilled delivery devices, novel therapeutic modalities and more efficient approaches to oral peptide delivery. The conference provides an excellent opportunity to exchange insights with formulation scientists, drug-product developers and delivery specialists addressing the growing complexity of modern therapeutics.
If you are attending MIBio 2026 and would like to learn how mSAS® could support your formulation or drug-delivery programme, contact the CrystecPharma team to arrange a meeting.
Find out more about MIBio 2026
Event: 14th MIBio Conference
Date: 14 October 2026
Venue: Howard Theatre, Downing College, Cambridge